Kashif Firozvi

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization

Siraj M. Ali, Thomas A. Hensing, Alexa B. Schrock et al. · The Oncologist · 2016 · 115 citations · Full text

Medicine, Genetics, Oncology +17

Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate

Kashif Firozvi, Ruby Anne E. Deveras, Craig M. Kessler · American Journal of Hematology · 2006 · 45 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

Michael J. Pishvaian, Rebecca Slack, Eunice Y. Koh et al. · Cancer Chemotherapy and Pharmacology · 2012 · 17 citations

Medicine, Oncology, Pharmacology +10

A phase I study of the pan-Bcl2 family inhibitor GX15–070, administered as a 3-hour weekly infusion in patients with refractory solid tumors or lymphomas

Kashif Firozvi, Justin H. Hwang, Nora Hansen et al. · Journal of Clinical Oncology · 2006 · 10 citations

Medicine, Oncology, Pharmacology +16